Displaying 581 - 600 of 1776
FTC Publishes Inflation-Adjusted Civil Penalty Amounts
FTC Approves Final Order Requiring Bristol-Myers Squibb Company and Celgene Corporation to Divest Psoriasis Drug Otezla as a Condition of Acquisition
FTC Staff Comment to the Kansas House of Representatives Concerning Kansas House Bill 2412
FTC Staff Comment to the Ohio House of Representatives Concerning Ohio House Bill 177
Joint Vertical Merger Guidelines (Draft Released for Public Comment)
Concurring Statement of Commissioner Christine S. Wilson Concerning the Publication of FTC-DOJ Draft Vertical Merger Guidelines for Public Comment
FTC and DOJ Announce Draft Vertical Merger Guidelines for Public Comment
Statement of Commissioner Rohit Chopra Regarding the Request for Comment on Vertical Merger Guidelines
FTC Challenges Consummated Merger of Companies that Market Body-Worn Camera Systems to Large Metropolitan Police Departments
Statement of Gail Levine, Deputy Director of FTC Bureau of Competition, Regarding the Announcement that Illumina Inc. has Abandoned Its Proposed Acquisition of Pacific Biosciences of California
FTC Alleges Post Holdings, Inc.’s Proposed Acquisition of TreeHouse Foods, Inc.’s Private Label Ready-to-Eat Cereal Business Will Harm Competition
FTC Chairman Simons Announces Senior Appointments in Bureau of Competition
Third Point LLC
Investment advisor Third Point LLC and three funds that it controls have agreed to settle Federal Trade Commission charges that the funds violated the premerger notification and waiting period requirements of the Hart-Scott-Rodino Act, or HSR Act, after they acquired the voting securities of DowDuPont Inc. According to the complaint, on Aug. 31, 2017, the shares of Dow Inc. held by the three Third Point funds – Third Point Partners Qualified L.P., Third Point Ultra, Ltd., and Third Point Offshore Fund Ltd. – converted to shares of the newly formed DowDuPont Inc. following the merger of Dow Inc. and E.I. du Pont de Nemours & Company. The three funds have agreed to collectively pay $609,810 in civil penalties, and they, together with Third Point LLC, will be barred from committing future violations of the HSR Act in connection with corporate consolidations.
FTC Challenges Illumina’s Proposed Acquisition of PacBio
FTC Again Named One of the Best Places to Work in the Federal Government
Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.
Deputy Bureau of Competition Director Marian Bruno Retiring
FTC Approves Final Order Imposing Conditions on NEXUS Gas Transmission, LLC’s Acquisition of Generation Pipeline LLC
Federal Trade Commission's Statement of Public Interest
Displaying 581 - 600 of 1776